 | A50 | Name: | 2-({4'-pentyl-3'-[2-(pyridin-2-yl)ethyl][1,1'-biphenyl]-4-yl}sulfonyl)ethan-1-ol | Formula: | C26 H31 N O3 S | SMILES: | c3c(S(CCO)(=O)=O)ccc(c2cc(CCc1ccccn1)c(cc2)CCCCC)c3 | InChi: | InChI=1S/C26H31NO3S/c1-2-3-4-7-21-9-10-23(20-24(21)11-14-25-8-5-6-17-27-25)22-12-15-26(16-13-22)31(29,30)19-18-28/h5-6,8-10,12-13,15-17,20,28H,2-4,7,11,14,18-19H2,1H3 | Definition date: | 2018-09-21 | Last modified: | 2019-02-22 | Release date: | 2019-02-27 | Identifier: | 2-({4'-pentyl-3'-[2-(pyridin-2-yl)ethyl][1,1'-biphenyl]-4-yl}sulfonyl)ethan-1-ol |
|
 | A59 | Name: | 2-({4'-pentyl-3'-[(Z)-2-(pyridin-2-yl)ethenyl][1,1'-biphenyl]-4-yl}sulfonyl)ethan-1-ol | Formula: | C26 H29 N O3 S | SMILES: | c3c(S(CCO)(=O)=O)ccc(c2cc([C@H]=Cc1ccccn1)c(cc2)CCCCC)c3 | InChi: | InChI=1S/C26H29NO3S/c1-2-3-4-7-21-9-10-23(20-24(21)11-14-25-8-5-6-17-27-25)22-12-15-26(16-13-22)31(29,30)19-18-28/h5-6,8-17,20,28H,2-4,7,18-19H2,1H3/b14-11- | Definition date: | 2018-09-21 | Last modified: | 2019-02-22 | Release date: | 2019-02-27 | Identifier: | 2-({4'-pentyl-3'-[(Z)-2-(pyridin-2-yl)ethenyl][1,1'-biphenyl]-4-yl}sulfonyl)ethan-1-ol |
|
 | GKZ | Name: | 1-[2-[4-[4-(4-chlorophenyl)-3-methyl-1~{H}-pyrazol-5-yl]-3-oxidanyl-phenoxy]ethyl]piperidin-1-ium-4-carboxamide | Formula: | C24 H28 Cl N4 O3 | SMILES: | Cc1n[nH]c(c2ccc(OCC[NH+]3CCC(CC3)C(N)=O)cc2O)c1c4ccc(Cl)cc4 | InChi: | InChI=1S/C24H27ClN4O3/c1-15-22(16-2-4-18(25)5-3-16)23(28-27-15)20-7-6-19(14-21(20)30)32-13-12-29-10-8-17(9-11-29)24(26)31/h2-7,14,17,30H,8-13H2,1H3,(H2,26,31)(H,27,28)/p+1 | Definition date: | 2018-09-28 | Last modified: | 2019-02-22 | Release date: | 2019-02-27 | Identifier: | 1-[2-[4-[4-(4-chlorophenyl)-3-methyl-1~{H}-pyrazol-5-yl]-3-oxidanyl-phenoxy]ethyl]piperidin-1-ium-4-carboxamide |
|
 | GNK | Name: | (1~{S},5~{R})-8-[2-(4-chlorophenyl)ethyl]-8-azabicyclo[3.2.1]octan-3-one | Formula: | C15 H18 Cl N O | SMILES: | Clc1ccc(CCN2[CH]3CC[CH]2CC(=O)C3)cc1 | InChi: | InChI=1S/C15H18ClNO/c16-12-3-1-11(2-4-12)7-8-17-13-5-6-14(17)10-15(18)9-13/h1-4,13-14H,5-10H2/t13-,14+ | Definition date: | 2018-09-28 | Last modified: | 2019-02-22 | Release date: | 2019-02-27 | Identifier: | (1~{S},5~{R})-8-[2-(4-chlorophenyl)ethyl]-8-azabicyclo[3.2.1]octan-3-one |
|
 | GNW | Name: | 1-[(3-chlorophenyl)methyl]piperazine | Formula: | C11 H15 Cl N2 | SMILES: | Clc1cccc(CN2CCNCC2)c1 | InChi: | InChI=1S/C11H15ClN2/c12-11-3-1-2-10(8-11)9-14-6-4-13-5-7-14/h1-3,8,13H,4-7,9H2 | Definition date: | 2018-09-29 | Last modified: | 2019-02-22 | Release date: | 2019-02-27 | Identifier: | 1-[(3-chlorophenyl)methyl]piperazine |
|
 | GNZ | Name: | (1~{S},5~{R})-8-[2-[4-(trifluoromethyl)phenyl]ethyl]-8-azabicyclo[3.2.1]octan-3-one | Formula: | C16 H18 F3 N O | SMILES: | FC(F)(F)c1ccc(CCN2[CH]3CC[CH]2CC(=O)C3)cc1 | InChi: | InChI=1S/C16H18F3NO/c17-16(18,19)12-3-1-11(2-4-12)7-8-20-13-5-6-14(20)10-15(21)9-13/h1-4,13-14H,5-10H2/t13-,14+ | Definition date: | 2018-09-29 | Last modified: | 2019-02-22 | Release date: | 2019-02-27 | Identifier: | (1~{S},5~{R})-8-[2-[4-(trifluoromethyl)phenyl]ethyl]-8-azabicyclo[3.2.1]octan-3-one |
|
 | GO2 | Name: | 1-(1,3-benzothiazol-2-yl)guanidine | Formula: | C8 H8 N4 S | SMILES: | NC(=N)Nc1sc2ccccc2n1 | InChi: | InChI=1S/C8H8N4S/c9-7(10)12-8-11-5-3-1-2-4-6(5)13-8/h1-4H,(H4,9,10,11,12) | Definition date: | 2018-09-29 | Last modified: | 2019-02-22 | Release date: | 2019-02-27 | Identifier: | 1-(1,3-benzothiazol-2-yl)guanidine |
|
 | GO5 | Name: | (1~{R},5~{S})-9-[2-(4-chlorophenyl)ethyl]-9-azabicyclo[3.3.1]nonan-3-one | Formula: | C16 H20 Cl N O | SMILES: | Clc1ccc(CCN2[CH]3CCC[CH]2CC(=O)C3)cc1 | InChi: | InChI=1S/C16H20ClNO/c17-13-6-4-12(5-7-13)8-9-18-14-2-1-3-15(18)11-16(19)10-14/h4-7,14-15H,1-3,8-11H2/t14-,15+ | Definition date: | 2018-09-29 | Last modified: | 2019-02-22 | Release date: | 2019-02-27 | Identifier: | (1~{R},5~{S})-9-[2-(4-chlorophenyl)ethyl]-9-azabicyclo[3.3.1]nonan-3-one |
|
 | GO8 | Name: | 8-propan-2-ylsulfanyl-7~{H}-purin-6-amine | Formula: | C8 H11 N5 S | SMILES: | CC(C)Sc1[nH]c2c(N)ncnc2n1 | InChi: | InChI=1S/C8H11N5S/c1-4(2)14-8-12-5-6(9)10-3-11-7(5)13-8/h3-4H,1-2H3,(H3,9,10,11,12,13) | Definition date: | 2018-09-29 | Last modified: | 2019-02-22 | Release date: | 2019-02-27 | Identifier: | 8-propan-2-ylsulfanyl-7~{H}-purin-6-amine |
|
 | GOE | Name: | 1-(6-methylpyridin-2-yl)-3-propyl-urea | Formula: | C10 H15 N3 O | SMILES: | CCCNC(=O)Nc1cccc(C)n1 | InChi: | InChI=1S/C10H15N3O/c1-3-7-11-10(14)13-9-6-4-5-8(2)12-9/h4-6H,3,7H2,1-2H3,(H2,11,12,13,14) | Definition date: | 2018-09-29 | Last modified: | 2019-02-22 | Release date: | 2019-02-27 | Identifier: | 1-(6-methylpyridin-2-yl)-3-propyl-urea |
|
 | GON | Name: | 1-[2-[3-oxidanyl-4-(4-phenyl-1~{H}-pyrazol-5-yl)phenoxy]ethyl]piperidine-4-carboxamide | Formula: | C23 H26 N4 O3 | SMILES: | NC(=O)C1CCN(CCOc2ccc(c(O)c2)c3[nH]ncc3c4ccccc4)CC1 | InChi: | InChI=1S/C23H26N4O3/c24-23(29)17-8-10-27(11-9-17)12-13-30-18-6-7-19(21(28)14-18)22-20(15-25-26-22)16-4-2-1-3-5-16/h1-7,14-15,17,28H,8-13H2,(H2,24,29)(H,25,26) | Definition date: | 2018-10-01 | Last modified: | 2019-02-22 | Release date: | 2019-02-27 | Identifier: | 1-[2-[3-oxidanyl-4-(4-phenyl-1~{H}-pyrazol-5-yl)phenoxy]ethyl]piperidine-4-carboxamide |
|
 | 9AU | Name: | 4-oxidanyl-3-[(2~{E},6~{E})-3,7,11-trimethyldodeca-2,6,10-trienyl]chromen-2-one | Formula: | C24 H30 O3 | SMILES: | CC(C)=CCCC(C)=CCCC(C)=CCC1=C(O)c2ccccc2OC1=O | InChi: | InChI=1S/C24H30O3/c1-17(2)9-7-10-18(3)11-8-12-19(4)15-16-21-23(25)20-13-5-6-14-22(20)27-24(21)26/h5-6,9,11,13-15,25H,7-8,10,12,16H2,1-4H3/b18-11+,19-15+ | Definition date: | 2018-02-26 | Last modified: | 2019-02-22 | Release date: | 2019-02-27 | Identifier: | 4-oxidanyl-3-[(2~{E},6~{E})-3,7,11-trimethyldodeca-2,6,10-trienyl]chromen-2-one |
|
 | 9FO | Name: | 3,6,9,12,15,18,21,24,27,30,33,36,39,42,45,48,51,54,57-nonadecaoxanonapentacontane-1,59-diol | Formula: | C40 H82 O21 | SMILES: | OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO | InChi: | InChI=1S/C40H82O21/c41-1-3-43-5-7-45-9-11-47-13-15-49-17-19-51-21-23-53-25-27-55-29-31-57-33-35-59-37-39-61-40-38-60-36-34-58-32-30-56-28-26-54-24-22-52-20-18-50-16-14-48-12-10-46-8-6-44-4-2-42/h41-42H,1-40H2 | Definition date: | 2018-04-09 | Last modified: | 2019-02-22 | Release date: | 2019-02-27 | Identifier: | 3,6,9,12,15,18,21,24,27,30,33,36,39,42,45,48,51,54,57-nonadecaoxanonapentacontane-1,59-diol |
|
 | JSP | Name: | (1R)-1-(4-amino-1-methyl-2-oxo-1,2-dihydropyrimidin-5-yl)-1,4-anhydro-2-deoxy-5-O-phosphono-D-erythro-pentitol | Formula: | C10 H16 N3 O7 P | SMILES: | C1(=CN(C(=O)N=C1N)C)C2CC(C(COP(=O)(O)O)O2)O | InChi: | InChI=1S/C10H16N3O7P/c1-13-3-5(9(11)12-10(13)15)7-2-6(14)8(20-7)4-19-21(16,17)18/h3,6-8,14H,2,4H2,1H3,(H2,11,12,15)(H2,16,17,18)/t6-,7+,8+/m0/s1 | Definition date: | 2018-09-20 | Last modified: | 2019-02-22 | Release date: | 2019-02-27 | Identifier: | (1R)-1-(4-amino-1-methyl-2-oxo-1,2-dihydropyrimidin-5-yl)-1,4-anhydro-2-deoxy-5-O-phosphono-D-erythro-pentitol |
|
 | KUV | Name: | 5-amino-N-{5-[(4R,5R)-4-amino-5-fluoroazepan-1-yl]-1-methyl-1H-pyrazol-4-yl}-2-(2,6-difluorophenyl)-1,3-thiazole-4-carboxamide | Formula: | C20 H22 F3 N7 O S | SMILES: | n3(c(c(NC(c2nc(c1c(cccc1F)F)sc2N)=O)cn3)N4CCC(C(F)CC4)N)C | InChi: | InChI=1S/C20H22F3N7OS/c1-29-20(30-7-5-10(21)13(24)6-8-30)14(9-26-29)27-18(31)16-17(25)32-19(28-16)15-11(22)3-2-4-12(15)23/h2-4,9-10,13H,5-8,24-25H2,1H3,(H,27,31)/t10-,13-/m1/s1 | Definition date: | 2019-01-16 | Last modified: | 2019-02-22 | Release date: | 2019-02-27 | Identifier: | 5-amino-N-{5-[(4R,5R)-4-amino-5-fluoroazepan-1-yl]-1-methyl-1H-pyrazol-4-yl}-2-(2,6-difluorophenyl)-1,3-thiazole-4-carboxamide |
|
 | GUK | Name: | 6-chloranyl-3-(2~{H}-indazol-5-yl)-~{N}-propan-2-yl-imidazo[1,2-b]pyridazin-8-amine | Formula: | C16 H15 Cl N6 | SMILES: | CC(C)Nc1cc(Cl)nn2c(cnc12)c3ccc4n[nH]cc4c3 | InChi: | InChI=1S/C16H15ClN6/c1-9(2)20-13-6-15(17)22-23-14(8-18-16(13)23)10-3-4-12-11(5-10)7-19-21-12/h3-9,20H,1-2H3,(H,19,21) | Definition date: | 2018-10-10 | Last modified: | 2019-02-22 | Release date: | 2019-02-27 | Identifier: | 6-chloranyl-3-(2~{H}-indazol-5-yl)-~{N}-propan-2-yl-imidazo[1,2-b]pyridazin-8-amine |
|
 | GXK | Name: | 6-chloranyl-~{N}-(cyclopropylmethyl)-3-(2~{H}-indazol-5-yl)imidazo[1,2-b]pyridazin-8-amine | Formula: | C17 H15 Cl N6 | SMILES: | Clc1cc(NCC2CC2)c3ncc(n3n1)c4ccc5n[nH]cc5c4 | InChi: | InChI=1S/C17H15ClN6/c18-16-6-14(19-7-10-1-2-10)17-20-9-15(24(17)23-16)11-3-4-13-12(5-11)8-21-22-13/h3-6,8-10,19H,1-2,7H2,(H,21,22) | Definition date: | 2018-10-16 | Last modified: | 2019-02-22 | Release date: | 2019-02-27 | Identifier: | 6-chloranyl-~{N}-(cyclopropylmethyl)-3-(2~{H}-indazol-5-yl)imidazo[1,2-b]pyridazin-8-amine |
|
 | GXN | Name: | [2-[(3-bromanyl-4,5-dimethoxy-phenyl)methyl]-7-methoxy-3,4-dihydro-1~{H}-isoquinolin-6-yl] sulfamate | Formula: | C19 H23 Br N2 O6 S | SMILES: | COc1cc2CN(CCc2cc1O[S](N)(=O)=O)Cc3cc(Br)c(OC)c(OC)c3 | InChi: | InChI=1S/C19H23BrN2O6S/c1-25-16-9-14-11-22(5-4-13(14)8-17(16)28-29(21,23)24)10-12-6-15(20)19(27-3)18(7-12)26-2/h6-9H,4-5,10-11H2,1-3H3,(H2,21,23,24) | Definition date: | 2018-10-17 | Last modified: | 2019-02-22 | Release date: | 2019-02-27 | Identifier: | [2-[(3-bromanyl-4,5-dimethoxy-phenyl)methyl]-7-methoxy-3,4-dihydro-1~{H}-isoquinolin-6-yl] sulfamate |
|
 | GZK | Name: | 1-[(3~{R})-1,1-bis(oxidanylidene)thiolan-3-yl]-5-[(3,4-dichlorophenyl)methyl]pyrazolo[3,4-d]pyrimidin-4-one | Formula: | C16 H14 Cl2 N4 O3 S | SMILES: | Clc1ccc(CN2C=Nc3n(ncc3C2=O)[CH]4CC[S](=O)(=O)C4)cc1Cl | InChi: | InChI=1S/C16H14Cl2N4O3S/c17-13-2-1-10(5-14(13)18)7-21-9-19-15-12(16(21)23)6-20-22(15)11-3-4-26(24,25)8-11/h1-2,5-6,9,11H,3-4,7-8H2/t11-/m1/s1 | Definition date: | 2018-10-27 | Last modified: | 2019-02-22 | Release date: | 2019-02-27 | Identifier: | 1-[(3~{R})-1,1-bis(oxidanylidene)thiolan-3-yl]-5-[(3,4-dichlorophenyl)methyl]pyrazolo[3,4-d]pyrimidin-4-one |
|
 | GZN | Name: | 2-[(3,4-dichlorophenyl)methyl]-~{N}-(1-methylpyrazol-4-yl)-1-oxidanylidene-isoquinoline-4-carboxamide | Formula: | C21 H16 Cl2 N4 O2 | SMILES: | Cn1cc(NC(=O)C2=CN(Cc3ccc(Cl)c(Cl)c3)C(=O)c4ccccc24)cn1 | InChi: | InChI=1S/C21H16Cl2N4O2/c1-26-11-14(9-24-26)25-20(28)17-12-27(10-13-6-7-18(22)19(23)8-13)21(29)16-5-3-2-4-15(16)17/h2-9,11-12H,10H2,1H3,(H,25,28) | Definition date: | 2018-10-27 | Last modified: | 2019-02-22 | Release date: | 2019-02-27 | Identifier: | 2-[(3,4-dichlorophenyl)methyl]-~{N}-(1-methylpyrazol-4-yl)-1-oxidanylidene-isoquinoline-4-carboxamide |
|
 | GZQ | Name: | ~{N}-(2,4-dichlorophenyl)-~{N}-methyl-ethanamide | Formula: | C9 H9 Cl2 N O | SMILES: | CN(C(C)=O)c1ccc(Cl)cc1Cl | InChi: | InChI=1S/C9H9Cl2NO/c1-6(13)12(2)9-4-3-7(10)5-8(9)11/h3-5H,1-2H3 | Definition date: | 2018-10-27 | Last modified: | 2019-02-22 | Release date: | 2019-02-27 | Identifier: | ~{N}-(2,4-dichlorophenyl)-~{N}-methyl-ethanamide |
|
 | GZT | Name: | 1-[[2,2-bis(fluoranyl)-1,3-benzodioxol-5-yl]methyl]-~{N}-methyl-2-oxidanylidene-pyridine-3-carboxamide | Formula: | C15 H12 F2 N2 O4 | SMILES: | CNC(=O)C1=CC=CN(Cc2ccc3OC(F)(F)Oc3c2)C1=O | InChi: | InChI=1S/C15H12F2N2O4/c1-18-13(20)10-3-2-6-19(14(10)21)8-9-4-5-11-12(7-9)23-15(16,17)22-11/h2-7H,8H2,1H3,(H,18,20) | Definition date: | 2018-10-27 | Last modified: | 2019-02-22 | Release date: | 2019-02-27 | Identifier: | 1-[[2,2-bis(fluoranyl)-1,3-benzodioxol-5-yl]methyl]-~{N}-methyl-2-oxidanylidene-pyridine-3-carboxamide |
|
 | GZW | Name: | 2-[(3,4-dichlorophenyl)methyl]-~{N}-(1-methylpyrazol-4-yl)-1-oxidanylidene-6-piperidin-4-yl-2,7-naphthyridine-4-carboxamide | Formula: | C25 H24 Cl2 N6 O2 | SMILES: | Cn1cc(NC(=O)C2=CN(Cc3ccc(Cl)c(Cl)c3)C(=O)c4cnc(cc24)C5CCNCC5)cn1 | InChi: | InChI=1S/C25H24Cl2N6O2/c1-32-13-17(10-30-32)31-24(34)20-14-33(12-15-2-3-21(26)22(27)8-15)25(35)19-11-29-23(9-18(19)20)16-4-6-28-7-5-16/h2-3,8-11,13-14,16,28H,4-7,12H2,1H3,(H,31,34) | Definition date: | 2018-10-27 | Last modified: | 2019-02-22 | Release date: | 2019-02-27 | Identifier: | 2-[(3,4-dichlorophenyl)methyl]-~{N}-(1-methylpyrazol-4-yl)-1-oxidanylidene-6-piperidin-4-yl-2,7-naphthyridine-4-carboxamide |
|
 | H08 | Name: | 2-[(4-chlorophenyl)methyl]-~{N}-(1-methylpyrazol-4-yl)-1-oxidanylidene-isoquinoline-4-carboxamide | Formula: | C21 H17 Cl N4 O2 | SMILES: | Cn1cc(NC(=O)C2=CN(Cc3ccc(Cl)cc3)C(=O)c4ccccc24)cn1 | InChi: | InChI=1S/C21H17ClN4O2/c1-25-12-16(10-23-25)24-20(27)19-13-26(11-14-6-8-15(22)9-7-14)21(28)18-5-3-2-4-17(18)19/h2-10,12-13H,11H2,1H3,(H,24,27) | Definition date: | 2018-10-27 | Last modified: | 2019-02-22 | Release date: | 2019-02-27 | Identifier: | 2-[(4-chlorophenyl)methyl]-~{N}-(1-methylpyrazol-4-yl)-1-oxidanylidene-isoquinoline-4-carboxamide |
|
 | H0B | Name: | 6-[(3,4-dichlorophenyl)methyl]-~{N}-(1-methylpyrazol-4-yl)-5-oxidanylidene-1,6-naphthyridine-8-carboxamide | Formula: | C20 H15 Cl2 N5 O2 | SMILES: | Cn1cc(NC(=O)C2=CN(Cc3ccc(Cl)c(Cl)c3)C(=O)c4cccnc24)cn1 | InChi: | InChI=1S/C20H15Cl2N5O2/c1-26-10-13(8-24-26)25-19(28)15-11-27(9-12-4-5-16(21)17(22)7-12)20(29)14-3-2-6-23-18(14)15/h2-8,10-11H,9H2,1H3,(H,25,28) | Definition date: | 2018-10-27 | Last modified: | 2019-02-22 | Release date: | 2019-02-27 | Identifier: | 6-[(3,4-dichlorophenyl)methyl]-~{N}-(1-methylpyrazol-4-yl)-5-oxidanylidene-1,6-naphthyridine-8-carboxamide |
|